CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3327-3333

  Lu, Pin ^b   Urban, Joseph F ^a   Di Zhou, Xia ^b   Chen, S J ^b   Madden, Kathleen ^b   Moorman, Mark ^b   Nguyen, Huong ^b   Morris, Suzanne C ^c   Finkelman, Fred D ^c   Gause, William C ^a,b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN G1; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; EOSINOPHILIA; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MASTOCYTOSIS; MOUSE; NEMATODIASIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, HELMINTH; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; B-LYMPHOCYTES; BINDING, COMPETITIVE; CD40 LIGAND; CYTOKINES; EOSINOPHILIA; FEMALE; GENE EXPRESSION REGULATION; HYPERSENSITIVITY; IMMUNOGLOBULIN G; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MASTOCYTOSIS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEMATOSPIROIDES DUBIUS; STRONGYLIDA INFECTIONS; T-LYMPHOCYTES;

EID: 9244230102     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand CD40. J. Exp. Med. 178:669.
2. Armitage, R. J., T. W. Tough, B. M. Macduff, W. C. Fanslow, M. K. Spriggs, F. Ramsdell, and M. R. Alderson. 1993. CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23:2326.
3. Hollenbaugh, D., H. D. Ochs, R. J. Noelle, J. A. Ledbetter, and A. Aruffo. 1994. The role of CD40 and its ligand in the regulation of the immune response. Immunol Rev. 138:23.
4. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y. J. Lui, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
5. Gauchat, J.-F., S. Henchoz, G. Mazzel, J.-P. Aubry, T. Brunner, H. Blasey, P. Life, D. Talabot, L. Flores-Romo, J. Thompson, K. Kishi, J. Butterfield, C. Dahinden, and J.-Y. Bonnefoy. 1993. Induction of human IgE synthesis by mast cells and basophils. Nature 365:340.
6. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblat, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, D. K. Simoneaux, W. C. Fanslow, J. Belmont, and M. K. Spriggs. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990.
7. DiSanto, J. P., J. U. Bonnefoy, J. F. Gauchat, A. Fischer, and G. de Saint-Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541.
8. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. S. Grosamire, R. Stenkamp, M. Neubauer, R. L. Roberts, R. J. Noelle, J. A. Ledbetter, U. Francke, and H. D. Ochs. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291.
9. Korthauer, U., D. Graf, H. W. Mages, F. Briere, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinsky, and R. A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539.
10. Fanslow, W. C., K. N. Clifford, M. Seamon, M. R. Alderson, N. K. Spriggs, R. J. Armitage, and F. Ramsdell. 1994. Recombinant CD40 ligand exerts potent biologic effects on T cells. J. Immunol. 152:4262.
11. Ramsdell, F., M. S. Seaman, K. N. Clifford, and W. C. Fanslow. 1994. CD40 ligand acts as a costimulatory signal for neonatal thymic γδ T cells. J. Immunol. 152:2190.
12. Uckun, F. M., G. L. Schieven, I. Dibirdik, M. Chandan-Langlie, L. Tuel-Ahlgren, and J. A. Ledbetter. 1991. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B cell ontogeny. J. Biol. Chem. 266:17478.
13. Barrett, T. B., G. Shu, and E. A. Clark. 1994. CD40 signaling activates CD11a/ CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146:1722.
14. Clark, E. A., and J. A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83:4494.
15. Gordon, J., M. J. Millsum, G. Guy, and J. A. Ledbetter. 1987. Synergistic interaction between interleukin 4 and anti-bp50 (CDw40) revealed in a novel B cell restimulation assay. Eur. J. Immunol 17:1535.
16. Rousset, F., E. Garcia, and J. Banchereau. 1991. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigens. J. Exp. Med. 173:705.
17. Tsitsikov, E. N., N. Ramesh, and R. S. Geha. 1994. Structure of the murine CD40 ligand gene. Mol. Immunol. 31:895.
18. + T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 147:8.
19. Clark, E. A., and G. Shu. 1990. Association between IL-6 and CD40 signaling: IL-6 induces phosphorylation of CD40 receptors. J. Immunol. 145:1400.
20. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
21. Klaus, S. J., L. M. Pinchuk, H. D. Ochs, C. L. Law, W. C. Fanslow, R. J. Armitage, and E. A. Clark. 1994. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152:5643.
22. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. II. Prolonged suppression of primary and secondary humoral immune responses by an antibody targeted to the CD40 ligand, gp39. J. Exp. Med. 178: 1567.
23. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med 180:157.
24. Dune, F. H., A. Aruffo, J. Ledbetter, K. M. Crassi, W. R. Green, L. D. Fast, and R. J. Noelle. 1994. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94:1333.
25. Svetic, A., K. B. Madden, X. D. Zhou, P. Lu, I. M. Katona, F. D. Finkelman, J. F. Urban, and W. C. Gause. 1993. A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J. Immunol. 150:3434.
26. Urban, J. F., K. B. Madden, A. Svetic, A. Cheever, P. P. Trotta, W. C. Gause, I. M. Katona, and F. D. Finkelman. 1992. The importance of Th2 cytokines in protective immunity to nematodes. Immunol. Rev. 127:205.
27. Lu, P., X. Zhou, S. J. Chen, M. Moorman, S. C. Morris, F. D. Finkelman, P. Linsley, J. F. Urban, and W. C. Gause. 1994. CTLA-4 ligands are required in an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J. Exp. Med. 180:693.
28. Finkelman, F. D., J. F. Urban, Jr., M. P. Beckmann, K. A. Schooley, J. M. Holmes, and I. M. Katona. 1991. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody. Int. Immunol. 3:599.
29. Kappler, J. W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted interleukin-2-producing T cell hybridomas. J. Exp. Med. 153:1198.
30. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. A. Wall, W. Havran, G. Otten, M. R. Loken, M. Pierres, J. Kappler, and F. W. Fitch. 1983. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:29.
31. Razi-Wolf, Z., Galvin, G. Gray, and H. Reiser. 1993. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor. Proc. Natl. Acad. Sci. USA 90:11182.
32. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631.
33. Chatelain, R., R. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182.
34. Abrams, J. S., M. G. Roncarolo, H. Yssel, V. Andersson, G. L. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
35. Svetic, A., F. D. Finkelman, Y. C. Jian, C. W. Dieffenbach, D. E. Scott, K. F. McCarthy, A. D. Steinberg, and W. C. Gause. 1991. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147:2391.
36. Lu, P., X. Zhou, S. Chen, M. Moorman, A. Schoneveld, S. Morris, F. D. Finkelman, P. Linsley, E. Claassen, and W. C. Gause. 1995. Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a systemic in vivo immune response. J. Immunol. 154:1078.
37. Madden, K. B., J. F. Urban, Jr., H. J. Ziltener, J. W. Schrader, F. D. Finkelman, and I. M. Katona. 1991. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J. Immunol. 147:1387.
38. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047.
39. Gause, W. C., and J. Adamovicz. 1994. The use of the PCR to quantitate gene expression. PCR Methods Appl. 3(Suppl.):123.
40. Durie, F. H., T. M. Foy, S. R. Masters, J. D. Laman, and R. J. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today.
41. Finkelman, F. D., J. Ohara, D. K. Goroff, J. Smith, N. Villacreses, J. J. Mond, and W. E. Paul. 1986. Production of BSF-I during an in vivo, T-dependent immune response. J. Immunol. 137:2878.
42. Noelle, R., P. H. Krammer, J. Ohara, J. W. Uhr, and E. S. Vitetta. 1984. Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. Proc. Natl. Acad. Sci. USA 81:6149.
43. Van den Eertwegh, A. J. M., R. J. Noelle, M. Roy, D. M. Shepherd, A. Aruffo, J. A. Ledbetter, W. J. A. Boersma, and E. Claassen. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp. Med. 178:1555.
44. Morris, S. C., A. Lees, J. Inman, and F. D. Finkelman. 1992. Role of antigen-specific T cell help in the generation of in vivo antibody responses. I. Antigen-specific T cell help is required to generate a polyclonal IgG1 response in anti-IgD antibody-injected mice. J. Immunol. 149:3836.
45. Stack, R. M., D. J. Lenschow, G. S. Gray, J. A. Bluestone, and F. W. Fitch. 1994. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J. Immunol. 152:5723.
46. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.